Literature DB >> 22067803

Characteristics of women who undergo second-trimester abortion in the setting of a fetal anomaly.

Jennifer L Kerns1, Megan Swanson, Sherri Pena, Danny Wu, Brian L Shaffer, Susan H Tran, Jody E Steinauer.   

Abstract

BACKGROUND: Most women diagnosed with a fetal anomaly terminate the pregnancy. Little is known about utilization of two procedures: dilation and evacuation (D&E) and induction termination. STUDY
DESIGN: This retrospective cohort study included all women seen at the University of California, San Francisco (UCSF) Prenatal Diagnosis Center (PDC) who underwent a second-trimester abortion for an anomalous pregnancy from 2005 to 2008. We abstracted variables from the PDC database and medical charts to identify predictors associated with undergoing D&E.
RESULTS: Three quarters of the 192 women underwent D&E (n=148). Higher maternal age, proximity to UCSF, earlier gestational age, singleton gestation and genetic anomaly were associated with undergoing D&E. In adjusted analysis, earlier gestational age and singleton gestation were associated with undergoing D&E.
CONCLUSIONS: The D&E procedure was more commonly utilized for terminating an anomalous pregnancy at UCSF than medical induction. Further inquiry is needed to explore how provider counseling influences the choice of D&E vs. induction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22067803     DOI: 10.1016/j.contraception.2011.04.012

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  2 in total

1.  Implications of Georgia's 20-Week Abortion Ban.

Authors:  Sarah C M Roberts; Heather Gould; Ushma D Upadhyay
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

2.  Abortion Trends in Georgia Following Enactment of the 22-Week Gestational Age Limit, 2007-2017.

Authors:  Kelli Stidham Hall; Sara Redd; Subasri Narasimhan; Elizabeth A Mosley; Sophie A Hartwig; Emily Lemon; Erin Berry; Eva Lathrop; Lisa B Haddad; Roger Rochat; Carrie Cwiak
Journal:  Am J Public Health       Date:  2020-05-21       Impact factor: 11.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.